Synthesis, Anti-HIV Activity, and Metabolic Stability of New Alkenyldiarylmethane (ADAM) HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Ítems similars

• Synthesis and Anti-HIV Activity of New Metabolically Stable Alkenyldiarylmethane (ADAM) Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Incorporating N-Methoxy Imidoyl Halide and 1,2,4-Oxadiazole Systems
  per: Sakamoto, Takeshi, et al.
  Publicat: (2007)
• Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors
  per: Deng, Bo-Liang, et al.
  Publicat: (2008)
• Investigation of the Alkenyldiarylmethane Non-nucleoside Reverse Transcriptase Inhibitors as Potential cAMP Phosphodiesterase-4B2 Inhibitors
  per: Cullen, Matthew D., et al.
  Publicat: (2007)
• Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years
  per: Chunlin Zhuang, et al.
  Publicat: (2020-06-01)
• Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years
  per: Zhuang, Chunlin, et al.
  Publicat: (2020)